CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
ADVANCE-VAC4PM aims to develop a vaccine for placental malaria, a serious condition affecting pregnant women. The project focuses on enhancing immune responses through innovative vaccine strategies and includes capacity building in Africa, as well as evaluating digital tools for tracking pregnancy outcomes.
Placental malaria (PM) is a severe disease that affects a particularly vulnerable demographic group, pregnant women.
The burden of disease is high, threatening more than 100 million women every year and causing the death of an estimated 50,000 pregnant women and up to 200,000 infants.
An effective vaccine would be an attractive tool to control PM on its own, or to complement the existing yet imperfect tools. ADVANCE-VAC4PM will build on the success of previously conducted first-in-human (phase I…
EUROPEAN VACCINE INITIATIVE EV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Denmark, Kobenhavn
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Denmark, Horsholm
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Netherlands, NIJMEGEN
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
